AKLOG LISHAN (Chairman and CEO) purchased 0.7% of their position (7.50K shares) of PAVMED INC. on the open market
Open‑market purchase worth $32.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/19/2021ACC: 0001094891-21-000143
DirectorOfficer10% Owner· Chairman and CEO
Since Jun 2018
+7.50K
Net shares
Net buyer
$32.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
7.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.50K
Price / share
$4.31
Trade value
$32.32K
% of position
0.7%
3/18/2021
1.10M→1.11M
Total
Net shares
+7.50K
Net value
$32.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2021 | P · Purchase | +7.50K | $4.31 | $32.32K | 0.7% | 1.10M | 1.11M |
| Total | +7.50K | $32.32K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned4.46M
Common Stock
IndirectShares owned2.28K
Common Stock
IndirectShares owned20K
Common Stock
IndirectShares owned2.30K
Total
4.48M indirect4.48M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.46M | Indirect |
| Common Stock | 2.28K | Indirect |
| Common Stock | 20K | Indirect |
| Common Stock | 2.30K | Indirect |
| Total | 4.48M | 4.48M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported